• 1. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 2. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 3. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Nitrobenzenes
• Solvents and Organic Chemicals Organic Compounds Acids/Esters
• Solvents and Organic Chemicals Organic Compounds Hydrocarbons

2-(2-Fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane: A Key Compound in Modern Pharmaceutical Research

2-(2-Fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, with the CAS No. 425378-68-3, represents a pivotal molecule in the field of biomedical chemistry. This compound, characterized by its unique 1,3,2-dioxaborolane framework and 2-fluoro-5-nitrophenyl substituent, has garnered significant attention for its potential applications in drug discovery and targeted therapy. Recent studies highlight its role in enhancing the efficacy of therapeutic agents through its ability to modulate molecular interactions.

The 1,3,2-dioxaborolane core of this compound is a versatile platform for chemical modification and functionalization. This structural feature allows for the incorporation of diverse functional groups, making it a valuable scaffold in the development of antibody-drug conjugates (ADCs) and small molecule inhibitors. Researchers have demonstrated that the 2-fluoro-5-nitrophenyl group significantly influences the compound's bioavailability and metabolic stability, which are critical factors in pharmaceutical formulations.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of 2-(2-fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane through transition-metal-catalyzed coupling reactions. These methods, such as Suzuki-Miyaura cross-coupling and Stille coupling, have been optimized to achieve high yields and purity, which are essential for preclinical studies and clinical trials. The use of organocatalysts and green chemistry principles further enhances the sustainability of its production.

Studies published in 2023 have shown that this compound exhibits promising antitumor activity against multidrug-resistant cancer cells. The nitrophenyl moiety is believed to interact with specific proteins involved in cell proliferation, thereby inhibiting mitotic processes. Additionally, its fluorinated substituent may contribute to metabolic stability, reducing the risk of drug metabolism in vivo.

The 4,4,5,5-tetramethyl groups in the 1,3,2-dioxaborolane ring provide steric bulk, which is crucial for enantioselective synthesis and stereospecific reactions. This structural feature allows for the precise control of molecular orientation, which is vital in the development of highly selective drugs. Researchers are exploring its potential in targeted drug delivery systems, where the compound's hydrophobic properties may facilitate cell membrane penetration.

Recent in vitro studies have demonstrated the compound's ability to modulate signal transduction pathways associated with apoptosis and cell cycle arrest. These findings suggest its potential as a chemotherapeutic agent or a targeted therapy for oncology applications. The nitrophenyl group's interaction with kinase enzymes is a focal point of current research, aiming to elucidate its mechanism of action.

Advances in computational chemistry have enabled the prediction of molecular dynamics and binding affinities for this compound. Machine learning models trained on large-scale datasets have identified potential binding sites on target proteins, which could accelerate the drug development process. These models are also being used to optimize synthetic pathways and reaction conditions for large-scale production.

The 1,3,2-dioxaborolane framework of this compound is also being explored for biodegradable materials and drug delivery systems. Its hydrolytic stability under physiological conditions makes it a suitable candidate for controlled release formulations. Researchers are investigating its potential in nanoparticle-based delivery systems, where the compound's solubility and compatibility with biomaterials are critical factors.

Current preclinical trials are focusing on the pharmacokinetics and pharmacodynamics of this compound in various animal models. These studies are crucial for understanding its toxicity profile and therapeutic window. The results of these trials will inform the design of clinical trials and the eventual regulatory approval process.

Moreover, the fluorinated substituent in this compound may offer advantages in imaging applications, such as positron emission tomography (PET) and magnetic resonance imaging (MRI). The fluorine atom's electronegativity and low molecular weight make it an ideal contrast agent, enhancing the resolution and accuracy of diagnostic imaging.

Collaborative efforts between pharmaceutical companies and academic institutions are driving the development of new therapeutic strategies involving this compound. These partnerships are leveraging high-throughput screening and automated synthesis techniques to expedite the drug discovery process. The integration of artificial intelligence in drug design is also playing a significant role in optimizing the chemical structure and functional properties of this compound.

As research continues, the potential applications of 2-(2-fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane are expanding beyond traditional pharmacological uses. Its unique chemical properties are being explored for biotechnology and nanotechnology applications, including biocompatible materials and smart drug delivery systems. These innovations underscore the importance of continued research and development in the field of biomedical chemistry.

In conclusion, the compound 2-(2-fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane is a promising candidate for novel therapeutic applications. Its unique structural features and chemical properties make it a valuable tool in the drug discovery and development process. Continued research and innovation in this area will undoubtedly lead to breakthroughs in biomedical science and clinical medicine.

• 68716-48-3(4,4,5,5-tetramethyl-2-(3-nitrophenyl)-1,3,2-dioxaborolane)
• 1288978-82-4(2-(4-fluoro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
• 428820-95-5(3,5-Dinitrophenylboronic acid, pinacol ester)
• 871329-51-0(3-Amino-5-nitrophenylboronic acid, pinacol ester)
• 819057-45-9(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline)
• 1218791-09-3(4-Fluoro-3-nitrophenylboronic acid, pinacol ester)
• 939968-60-2(3-Fluoro-4-nitrophenylboronic acid, pinacol ester)
• 171364-83-3(4,4,5,5-Tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane)
• 1189042-70-3(2-Fluoro-3-nitrophenylboronic acid, pinacol ester)
• 1073353-89-5(2-Fluoro-4-nitrophenylboronic Acid Pinacol Ester)